Franklin Resources
PRVB

Franklin Resources’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Franklin Resources’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,926
Closed -$124K – 2501
2022
Q1 		$124K Buy
+16,926
New +$101K ﹤0.01% 2256
2021
Q4 		– Sell
-15,401
Closed -$98K – 2580
2021
Q3 		$98K Buy
+15,401
New +$99K ﹤0.01% 2331

Other funds holding PRVB

Sessa Capital
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Franklin Resources's PRVB Position: Q2 2022 in Review

Franklin Resources sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2022, closing a stake of 16,926 shares — an estimated $124K sold.

Franklin Resources first reported a position in PRVB in Q3 2021 and held it in 2 quarters. The position peaked at $124K in Q1 2022. 115 funds tracked by Wall St. Rank hold PRVB as of Q2 2022.

  • Franklin Resources reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Franklin Resources sold 16,926 Provention Bio, Inc. Common Stock shares in Q2 2022, an estimated $124K.
  • Franklin Resources first reported a position in Provention Bio, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Franklin Resources's Provention Bio, Inc. Common Stock position peaked at $124K in Q1 2022.
  • 115 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2022.

Based on Franklin Resources's 13F filing for Q2 2022, filed 11 Aug 2022.